L

Lexicon Pharmaceuticals
D

LXRX

1.24000
USD
0.06
(5.08%)
مغلق
حجم التداول
120,768
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
450,614,586
أصول ذات صلة
ABBV
ABBV
2.030
(0.99%)
206.710 USD
AMGN
AMGN
6.28
(2.16%)
296.49 USD
BMY
BMY
0.645
(1.35%)
48.465 USD
GSK
GSK
0.105
(0.27%)
39.325 USD
JNJ
JNJ
1.930
(1.10%)
176.650 USD
LLY
LLY
16.80
(2.45%)
701.25 USD
MRK
MRK
1.500
(1.81%)
84.250 USD
NVO
NVO
1.500
(2.95%)
52.420 USD
PFE
PFE
0.055
(0.22%)
25.155 USD
REGN
REGN
14.73
(2.60%)
580.63 USD
المزيد
الأخبار المقالات

العنوان: Lexicon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.